Leo Puri resigns as Independent Director of HUL, cites global board commitments

Mumbai: Hindustan Unilever Limited (HUL) has announced the resignation of Leo Puri as an Independent Director of the company, effective June 30, 2025. Puri, who has been serving on HUL’s board, has stepped down due to an increase in his board commitments, including his proposed appointment to the board of a global entity.

Puri’s resignation is also because of the overboarding criteria for Independent Directors under the European Corporate Governance requirements, the FMCG major confirmed in a regulatory filing on the stock exchanges.

With his resignation, Puri will also step down as Chairperson of the Risk Management Committee, ESG Committee, and Independent Committee

Puri also holds independent directorships in Dr. Reddy’s Laboratories and Fortis Healthcare. At Dr. Reddy’s, he chairs the Stakeholders Relationship Committee and is a member of the Nomination, Governance, and Compensation Committee, as well as the Science, Technology, and Operations Committee.

As recent as December, he was also appointed as the Chairperson of Fortis Healthcare’s board.

In his resignation letter, Puri confirmed that his decision was solely based on increasing professional commitments and that there were no other material reasons for stepping down.